These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A double-blind, delayed-start trial of rasagiline in Parkinson's disease. Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E, ADAGIO Study Investigators. N Engl J Med; 2009 Sep 24; 361(13):1268-78. PubMed ID: 19776408 [Abstract] [Full Text] [Related]
4. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Barone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, Tolosa E, Weintraub D. Lancet Neurol; 2010 Jun 24; 9(6):573-80. PubMed ID: 20452823 [Abstract] [Full Text] [Related]
7. Efficacy, safety and tolerability of rasagiline as adjunctive therapy in elderly patients with Parkinson's disease. Tolosa E, Stern MB. Eur J Neurol; 2012 Feb 24; 19(2):258-64. PubMed ID: 21819487 [Abstract] [Full Text] [Related]
9. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study. Parkinson Study Group. Arch Neurol; 2005 Feb 24; 62(2):241-8. PubMed ID: 15710852 [Abstract] [Full Text] [Related]
13. Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients. Stern MB, Marek KL, Friedman J, Hauser RA, LeWitt PA, Tarsy D, Olanow CW. Mov Disord; 2004 Aug 24; 19(8):916-23. PubMed ID: 15300656 [Abstract] [Full Text] [Related]
14. Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease. Stocchi F, Rabey JM. Eur J Neurol; 2011 Dec 24; 18(12):1373-8. PubMed ID: 21895884 [Abstract] [Full Text] [Related]